LNSR
LENSAR IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$67.30M
P/E Ratio
—
EPS
$-2.84
Beta
0.84
52W High
$14.31
52W Low
$5.06
50-Day MA
$7.65
200-Day MA
$10.89
Dividend Yield
—
Profit Margin
-58.70%
Forward P/E
—
PEG Ratio
—
About LENSAR Inc
LENSAR, Inc., a commercial stage medical device company, is focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company is headquartered in Orlando, Florida.
Fundamentals
| Revenue (TTM) | $58.44M |
| Gross Profit (TTM) | $27.12M |
| EBITDA | $-20.08M |
| Operating Margin | -116.00% |
| Return on Equity | -1069.00% |
| Return on Assets | -22.30% |
| Revenue/Share (TTM) | $4.89 |
| Book Value | $-2.17 |
| Price-to-Book | 33.83 |
| Price-to-Sales (TTM) | 1.15 |
| EV/Revenue | 0.9 |
| EV/EBITDA | -1.04 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -4.20% |
| Shares Outstanding | $12.10M |
| Float | $8.67M |
| % Insiders | 18.81% |
| % Institutions | 49.52% |
Historical Volatility
HV 10-Day
55.61%
HV 20-Day
61.72%
HV 30-Day
65.06%
HV 60-Day
102.16%
HV Rank
87.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($8.50 target)
1
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/5/2026